Marksans Pharma UK arm gets marketing nod for Ibuprofen, Paracetamol Film-coated Tablets
Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary in UK RelonchemLimited has received Marketing Authorization for the product Ibuprofen and Paracetamol200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).
Medical Dialogues team had earlier reported that the Company's wholly owned subsidiary Relonchem Limited had received Marketing Authorization from UKMHRA for the Fluoxetine 10mg Capsules, Fluoxetine 30mg Capsules and Fluoxetine 60mg Capsules.
Marksans Pharma Limited headquartered at Mumbai, India is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets. The company's manufacturing facilities located in India, USA and UK are approved by several leading regulatory agencies including USFDA, UKMHRA and Australian TGA. The company's product portfolio spreads over major therapeutic segments of CVS, CNS, Anti-diabetic, Pain Management, Gastroenterological and Antiallergies. The company is marketing these products globally.
Read also: Marksans Pharma arm gets UK MHRA marketing authorization for oral emergency contraceptive pill
Next Story